Guangyuan Song

Interventional cardiologist / Cardiologist
Beijing An Zhen Hospital, Capital Medical University Experiment Research Center ?East Gate? - Beijing, China

Latest contributions

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

22 May 2025 – From EuroPCR 2025

Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.

TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation

Innovations in transcatheter aortic valve devices and techniques

22 May 2025 – From EuroPCR 2025

Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...

Innovations in transcatheter aortic valve devices and techniques

China experience in TAVI evolution

22 May 2025 – From EuroPCR 2025

This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...

China experience in TAVI evolution

TAVI Hotline: new devices, new approaches

15 May 2024 – From EuroPCR 2024

TAVI Hotline: new devices, new approaches

The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes

29 Nov 2022 – From PCR London Valves 2022

In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.